|
|
| | Asudemotide Basic information |
| Product Name: | Asudemotide | | Synonyms: | Asudemotide;L-Isoleucine, L-α-glutamyl-L-tyrosyl-L-tyrosyl-L-α-glutamyl-L-leucyl-L-phenylalanyl-L-valyl-L-asparaginyl- | | CAS: | 1018833-53-8 | | MF: | C58H80N10O17 | | MW: | 1189.3126 | | EINECS: | | | Product Categories: | | | Mol File: | 1018833-53-8.mol |  |
| | Asudemotide Chemical Properties |
| Boiling point | 1602.6±65.0 °C(Predicted) | | density | 1.309±0.06 g/cm3(Predicted) | | pka | 3.35±0.10(Predicted) | | Sequence | Glu-Tyr-Tyr-Glu-Leu-Phe-Val-Asn-Ile |
| | Asudemotide Usage And Synthesis |
| Uses | Asudemotide (S-588410) is a peptide of human DEP domain-containing protein 1A. Asudemotide is an immunostimulant. Asudemotide has a sequence of H-Glu-Tyr-Tyr-Glu-Leu-Phe-Val-Asn-Ile-OH. Asudemotide induces a tumor immune response in esophageal cancer. [1]. | | References | [1] H Daiko, et al.Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients. Cancer Immunol Immunother. 2020, 69, 11. DOI:10.1007/s00262-020-02619-3 |
| | Asudemotide Preparation Products And Raw materials |
|